IL1B and myocardial infarction: While Leet et al. reported that dapagliflozin reduced inflammatory cytokines IL-6/IL-1β and superoxide levels in a myocardial infarction model [175], Shi X et al. showed attenuation of pro-inflammatory cyclooxygenase-2 and IL-1β in a heart failure model [176].